Randomized, rater-blinded, controlled study of intravenous (IV) N-acetylcysteine (NAC) in hospitalized adults with respiratory tract disease and abnormal mucus secretion
W. Tang (Shanghai, China), D. Zhu (Jinhua, China), X. Zhang (Shanghai, China), V. Zanin (Bresso (Mi), Italy), P. Magrone (Bresso (Mi), Italy), A. Papi (Ferrara, Italy), J. Qu (Shanghai, China)
Source: International Congress 2022 – ALERT 1: COPD and hospital management
Session: ALERT 1: COPD and hospital management
Session type: Clinical trials session
Number: 714
  
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Tang (Shanghai, China), D. Zhu (Jinhua, China), X. Zhang (Shanghai, China), V. Zanin (Bresso (Mi), Italy), P. Magrone (Bresso (Mi), Italy), A. Papi (Ferrara, Italy), J. Qu (Shanghai, China). Randomized, rater-blinded, controlled study of intravenous (IV) N-acetylcysteine (NAC) in hospitalized adults with respiratory tract disease and abnormal mucus secretion. 714
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|